121 related articles for article (PubMed ID: 17942308)
21. Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior.
Bleickardt CJ; Mullins DE; Macsweeney CP; Werner BJ; Pond AJ; Guzzi MF; Martin FD; Varty GB; Hodgson RA
Psychopharmacology (Berl); 2009 Mar; 202(4):711-8. PubMed ID: 18923820
[TBL] [Abstract][Full Text] [Related]
22. Adventures in drug discovery: potent agents based on ligands for cell-surface receptors.
Maryanoff BE
Acc Chem Res; 2006 Nov; 39(11):831-40. PubMed ID: 17115723
[TBL] [Abstract][Full Text] [Related]
23. Pyridobenzodiazepines: a novel class of orally active, vasopressin V2 receptor selective agonists.
Failli AA; Shumsky JS; Steffan RJ; Caggiano TJ; Williams DK; Trybulski EJ; Ning X; Lock Y; Tanikella T; Hartmann D; Chan PS; Park CH
Bioorg Med Chem Lett; 2006 Feb; 16(4):954-9. PubMed ID: 16297621
[TBL] [Abstract][Full Text] [Related]
24. Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
Bishara B; Shiekh H; Karram T; Rubinstein I; Azzam ZS; Abu-Saleh N; Nitecki S; Winaver J; Hoffman A; Abassi ZA
J Pharmacol Exp Ther; 2008 Aug; 326(2):414-22. PubMed ID: 18467593
[TBL] [Abstract][Full Text] [Related]
25. Conivaptan: promise of treatment in heart failure.
Hoque MZ; Arumugham P; Huda N; Verma N; Afiniwala M; Karia DH
Expert Opin Pharmacother; 2009 Sep; 10(13):2161-9. PubMed ID: 19663609
[TBL] [Abstract][Full Text] [Related]
26. Discovery of highly selective brain-penetrant vasopressin 1a antagonists for the potential treatment of autism via a chemogenomic and scaffold hopping approach.
Ratni H; Rogers-Evans M; Bissantz C; Grundschober C; Moreau JL; Schuler F; Fischer H; Alvarez Sanchez R; Schnider P
J Med Chem; 2015 Mar; 58(5):2275-89. PubMed ID: 25654260
[TBL] [Abstract][Full Text] [Related]
27. [Vasopressin antagonists].
de Groote P
Arch Mal Coeur Vaiss; 2002 Feb; 95 Spec 4(5 Spec 4):59-61. PubMed ID: 11933560
[TBL] [Abstract][Full Text] [Related]
28. Effects of tolvaptan, an oral vasopressin V2 receptor antagonist, in hyponatremia.
Madias NE
Am J Kidney Dis; 2007 Aug; 50(2):184-7. PubMed ID: 17660019
[No Abstract] [Full Text] [Related]
29. Inhibitory effect of vasopressin receptor antagonist OPC-31260 on experimental brain oedema induced by global cerebral ischaemia.
Molnár AH; Varga C; Berkó A; Rojik I; Párducz A; László F; László FA
Acta Neurochir (Wien); 2008 Mar; 150(3):265-71. PubMed ID: 18288441
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot study.
Goldsmith SR; Elkayam U; Haught WH; Barve A; He W
J Card Fail; 2008 Oct; 14(8):641-7. PubMed ID: 18926434
[TBL] [Abstract][Full Text] [Related]
31. Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetamide derivatives as novel arginine vasopressin V(2) receptor agonists.
Tsukamoto I; Koshio H; Akamatsu S; Kuramochi T; Saitoh C; Yatsu T; Yanai-Inamura H; Kitada C; Yamamoto E; Sakamoto S; Tsukamoto S
Bioorg Med Chem; 2008 Nov; 16(21):9524-35. PubMed ID: 18835174
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: investigation of a peripheral mechanism.
Yalcin M; Aydin C
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):447-53. PubMed ID: 19702598
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
Mao ZL; Stalker D; Keirns J
Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
[TBL] [Abstract][Full Text] [Related]
34. Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonists.
Shen DM; Zhang F; Brady EJ; Candelore MR; Dallas-Yang Q; Ding VD; Dragovic J; Feeney WP; Jiang G; McCann PE; Mock S; Qureshi SA; Saperstein R; Shen X; Tamvakopoulos C; Tong X; Tota LM; Wright MJ; Yang X; Zheng S; Chapman KT; Zhang BB; Tata JR; Parmee ER
Bioorg Med Chem Lett; 2005 Oct; 15(20):4564-9. PubMed ID: 16102966
[TBL] [Abstract][Full Text] [Related]
35. Tolvaptan (Otsuka).
Doggrell SA
Curr Opin Investig Drugs; 2004 Sep; 5(9):977-83. PubMed ID: 15503654
[TBL] [Abstract][Full Text] [Related]
36. Biological half-life and organ distribution of [3H]8-arginine vasopressin following administration of vasopressin receptor antagonist OPC-31260.
Molnár AH; Varga C; Janáky T; Tóth G; Tóth G; Farkas J; László F; László FA
Regul Pept; 2007 Jun; 141(1-3):12-8. PubMed ID: 17258819
[TBL] [Abstract][Full Text] [Related]
37. Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior.
Ferris CF; Lu SF; Messenger T; Guillon CD; Heindel N; Miller M; Koppel G; Robert Bruns F; Simon NG
Pharmacol Biochem Behav; 2006 Feb; 83(2):169-74. PubMed ID: 16504276
[TBL] [Abstract][Full Text] [Related]
38. Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms.
Andrés M; Peña A; Derick S; Raufaste D; Trojnar J; Wisniewski K; Trueba M; Serradeil-Le Gal C; Guillon G
Eur J Pharmacol; 2004 Oct; 501(1-3):59-69. PubMed ID: 15464063
[TBL] [Abstract][Full Text] [Related]
39. Identification of novel selective V2 receptor non-peptide agonists.
Del Tredici AL; Vanover KE; Knapp AE; Bertozzi SM; Nash NR; Burstein ES; Lameh J; Currier EA; Davis RE; Brann MR; Mohell N; Olsson R; Piu F
Biochem Pharmacol; 2008 Oct; 76(9):1134-41. PubMed ID: 18761325
[TBL] [Abstract][Full Text] [Related]
40. Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial.
Udelson JE; Orlandi C; Ouyang J; Krasa H; Zimmer CA; Frivold G; Haught WH; Meymandi S; Macarie C; Raef D; Wedge P; Konstam MA; Gheorghiade M
J Am Coll Cardiol; 2008 Nov; 52(19):1540-5. PubMed ID: 19007589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
